Urinary tract infections in neonates with unexplained pathological indirect hyperbilirubinemia: Prevalence and

Elif Bahat Ozdogan1, Mehmet Mutlu2, Secil Arslansoyu Camlar1

  • 1Department of Pediatrics, Division of Pediatric Nephrology, Karadeniz Technical University, Faculty of Medicine, Trabzon, Turkey.

Pediatrics and Neonatology
|November 19, 2017
PubMed

Insights

Testing for urinary tract infections (UTIs) in newborns with unexplained jaundice is recommended. This study found a 12.2% UTI prevalence, highlighting the significance of screening and follow-up for these neonates.

Area of Science:

  • Neonatal Medicine
  • Pediatric Infectious Diseases
  • Clinical Diagnostics

Background:

  • The role of urinary tract infection (UTI) screening in neonates with unexplained indirect hyperbilirubinemia requiring phototherapy remains controversial.
  • This study investigated the prevalence and clinical significance of UTIs in this specific neonatal population.

Purpose of the Study:

  • To determine the prevalence of urinary tract infections (UTIs) in neonates presenting with unexplained indirect hyperbilirubinemia and requiring phototherapy.
  • To assess the significance of UTIs in this group, including associated renal abnormalities and recurrence rates.

Main Methods:

  • A cohort of 2- to 14-day-old neonates with indirect bilirubin levels above phototherapy thresholds and no other identified cause for hyperbilirubinemia were included.
  • Urinary tract infection (UTI) diagnosis was confirmed by two consecutive urine cultures with significant bacterial growth (>10,000 colonies).
  • Affected neonates underwent renal ultrasonography (US) and selected cases were followed for recurrent UTIs.

Main Results:

  • The study included 262 neonates, with a UTI prevalence of 12.2% and a 6.2% rate of concurrent bacteremia among UTI-positive cases.
  • Escherichia coli and Klebsiella pneumoniae were the predominant pathogens (81.2%).
  • Renal abnormalities detected by US included pelvicaliectasis (12.5%) and increased renal parenchymal echogenicity (12.5%). Recurrent UTIs were observed in 23.5% of followed-up patients over a mean of 52 months.

Conclusions:

  • Screening for urinary tract infections (UTIs) is warranted in neonates with unexplained pathological jaundice.
  • All newborns diagnosed with a UTI should undergo renal ultrasonography (US) and be monitored for recurrent infections.
Abstract

Related Concept Videos

Urinary Tract Infection I: Introduction01:26

Urinary Tract Infection I: Introduction

Urinary tract infections (UTIs) impact various parts of the urinary system, including the kidneys, ureters, bladder, and urethra. These infections are generally bacterial, with Escherichia coli being the most common causative agent, often originating from the gastrointestinal tract. However, other bacteria, such as Staphylococcus saprophyticus, Klebsiella pneumoniae, and Proteus mirabilis, are also known to cause UTIs. The type, location, and underlying complexity of the UTI guide both...
769
Urinary Tract Infection II: Pathophysiology01:25

Urinary Tract Infection II: Pathophysiology

The pathophysiology of urinary tract infections (UTIs) encompasses several progressive stages, beginning with bacterial colonization and culminating in potential systemic complications if untreated. UTIs are primarily initiated by bacteria, such as Escherichia coli, which often originate from the gastrointestinal tract and migrate to the urinary system through the periurethral area. This migration can occur via several routes, including improper hygiene practices, sexual activity, or...
825
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
344
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
258
Acute Pyelonephritis I: Introduction01:27

Acute Pyelonephritis I: Introduction

Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such...
778
Urinary Tract Infection IV: Nursing Management01:17

Urinary Tract Infection IV: Nursing Management

In managing urinary tract infections (UTIs) in nursing, a comprehensive assessment is essential. Begin by gathering subjective data, such as the patient’s complaints of dysuria (painful urination), urinary frequency, urgency, suprapubic pain, and any lower abdominal discomfort. This information can be complemented by questions regarding previous UTIs, sexual activity, and personal hygiene practices, which can provide insight into risk factors. Objective assessment should focus on signs...
517